“I am thrilled to live in Houston, home of the Texas Medical Center (TMC), the largest medical complex in the world. I am constantly blown away by the depth, breadth and quality of the science at the 57 member institutions of the TMC that cover every possible discipline in research and clinical medicine.    Working closely with my colleagues at MD Anderson it has been incredibly professionally rewarding to found Magnolia Neurosciences and Magnolia Tejas in this vibrant and diverse city with a growing and connected life sciences ecosystem.”

David M. Schubert


David M. Schubert has over 25 years of experience in corporate development, operations and executive management in the biotechnology industry. Mr. Schubert currently serves as President of Magnolia Tejas Corporation and Chief Operating Officer of Proniras Corporation (both Accelerator Life Science Partners’ portfolio companies). Mr. Schubert has served in c-level positions with Accelerator Life Science Partners for over 15 years.  During this time, Mr. Schubert served for two years as the Executive Director of the Houston Area Translational Research Consortium (HATRC) at Rice University. Prior to his time at HATRC and Accelerator Life Science Partners, Mr. Schubert led the spin-out of CellExSys from Targeted Genetics Corporation (CellExSys was acquired by Chromos Molecular Systems). Mr. Schubert began his career at Baxter Healthcare Corporation where he served in various strategic planning, sales and marketing roles in Europe and in the United States. Mr. Schubert currently serves on the Board of Directors of Be The Match, operated by The National Marrow Donor Program (NMDP), Be The Match Biotherapies, and Enventure (Houston, TX).

Mr. Schubert received an MBA degree with concentrations in Marketing and Management from The Pennsylvania State University, an M.S. in Biology with a concentration in Immunology from Utah State University and a BS in Biology and a BA in Psychology from Eastern Nazarene College in Quincy, Massachusetts.